1. Kemp S, Huffnagel IC, Linthorst GE, Wanders RJ, Engelen M. Adrenoleukodystrophy: neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol. 2016; 12:606–615. PMID:
27312864.
2. Huffnagel IC, Laheji FK, Aziz-Bose R, Tritos NA, Marino R, Linthorst GE, et al. The natural history of adrenal insufficiency in X-linked adrenoleukodystrophy: an international collaboration. J Clin Endocrinol Metab. 2019; 104:118–126. PMID:
30252065.
Article
3. ACMG Board of Directors. Points to consider for informed consent for genome/exome sequencing. Genet Med. 2013; 15:748–749. PMID:
23970068.
4. Salsano E, Tabano S, Sirchia SM, Colapietro P, Castellotti B, Gellera C, et al. Preferential expression of mutant ABCD1 allele is common in adrenoleukodystrophy female carriers but unrelated to clinical symptoms. Orphanet J Rare Dis. 2012; 7:10. PMID:
22280810.
Article
5. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17:405–424. PMID:
25741868.
Article
6. Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci. 1991; 13:254–261. PMID:
1817030.
Article
7. Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J Pediatr. 2005; 146:528–532. PMID:
15812458.
Article
8. Hong AR, Ryu OH, Kim SY, Kim SW. Korean Adrenal Gland and Endocrine Hypertension Study Group. Korean Endocrine Society. Characteristics of Korean patients with primary adrenal insufficiency: a registry-based nationwide survey in Korea. Endocrinol Metab (Seoul). 2017; 32:466–474. PMID:
29271619.
Article